Addressing coronavirus disease 2019 (COVID-19) means addressing racism, according to 2 experts in the latest episode of Managed Care Cast.
Addressing coronavirus disease 2019 (COVID-19) means addressing racism, wrote Ingrid Katz, MD, assistant professor at Harvard Medical School, and Abraar Karan, MD, MPH, DTM&H, an internist at the Brigham and Women's Hospital and Harvard Medical School, in an opinion piece published in British Medical Journal.
In the latest Managed Care Cast, they speak with Patricia Salber, MD, MBA, of The Doctor Weighs In, about the article, why racism is an issue for doctors to address, and how well medicine is or is not doing with respect to addressing racism in admission to and graduation from medical school, teaching and studying the health impacts of racism in medical teaching, and encouraging more minority medical students to train as medical researchers.
Listen above or through one of these podcast services:
Read the original article by Katz and Karan.
Read more about racial and ethnic disparities in health care:
Addressing Cancer Disparities Requires Asking Questions and Putting Aside Assumptions
Does Intersection of Racial, Gender Biases Affect Heart Failure Treatment Decisions?
Dr Anthony Fauci on Health Disparities Affecting People of Color
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Polatuzumab Vedotin and R-CHP Appropriate for Untreated DLBCL
April 24th 2024Population pharmacokinetic and exposure-response analyses revealed a favorable benefit-risk profilane for the treatment combination of polatuzumab vedotin and rituximab, cyclophosphamide, doxorubicin, and prednisone (R-CHP).
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Survey Results Reveal Potential Factors Slowing the Decline in Cardiovascular Mortality Rate
April 23rd 2024Research indicated that worsened glycemic, blood pressure, and obesity control, as well as increased alcohol consumption, leveled lipid control, and persistent socioeconomic disparities may have contributed to the decelerated cardiovascular mortality decline in recent years.
Read More
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More